This debate features Ralph DeFronzo, MD, and David Nathan, MD, taking sides for and against initial combination therapy in type 2 diabetes mellitus. The session begins Friday at 12:45 p.m. PT in Room 30 at the convention center. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.
Don’t miss: Are Two Better than One? Initial Combination Therapy in Type 2 Diabetes Mellitus
